Sign up to save your podcasts
Or
Share Variation in Endpoints for FDA Approved Migraine Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Variation in Endpoints for FDA Approved Migraine Therapies
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343
View all episodes
By American Academy of Neurology
4.8
132132 ratings
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343
More shows like Neurology Minute
View all
NEJM This Week
327 Listeners
JAMA Clinical Reviews
500 Listeners
Neurology® Podcast
301 Listeners
Practical Neurology Podcast
55 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,379 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Neurology Today in 5
25 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Neurology Exam Prep Podcast
187 Listeners
Continuum Audio
83 Listeners